RE:NASHI dont know what was going on on the post. Let me post again.
To me, the NASH evolution is interesting. On the corporate slide posted on March 2022 said that External US based biopharma advisory firm retained to assist in identifying potential partner. And the latest slide said that "Actively pursuing discussions with companies that have interest, capabilities and resources". Obviously, they want to work with big pharma and they have already find their target. The ongoing discussion probably focusing on the trial design, data or maybe contract details.
Hopes as soo as the water issue is solved, the PR regarding the partnership on NASH can be anounced followed by skyrocketing share price.